Clinical trial reportAnnals of the rheumatic diseasesPublished
A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Annals of the rheumatic diseases
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Recurrence; Glucocorticoids; Treatment Outcome; Remission Induction; Double-Blind Method; Aged; Aged, 80 and over; Middle Aged; Female; Male; Giant Cell Arteritis
- PubMed ID
- 41688258
- Added to directory
- Source checked